A Multicenter, Randomized, Open-Label, Therapeutic, and Exploratory Trial to Evaluate the Tolerability and Efficacy of Platelet Glycoprotein IIb/IIIa Receptor Blocker (Clotinab™) in High-Risk Patients with Percutaneous Coronary Intervention

PURPOSE: This study was designed as a multicenter, randomized, open-label study to evaluate the efficacy and tolerability of Clotinab™. We expected to obtain same results as with ReoPro® in improving ischemic cardiac complications in high-risk patients who were about to undergo percutaneous coronary...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Moon, Jae-Youn, Kim, Weon, Kim, Ju Han, Ahn, Youngkeun, Jeong, Myung Ho, Kim, Young-Hak, Hong, Myeong-Ki, Park, Seong-Wook, Park, Seung-Jung, Park, Sungha, Ko, Young-Guk, Choi, Donghoon, Jang, Yangsoo
Formato: Artigo
Idioma:Inglês
Publicado em: Yonsei University College of Medicine 2008
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2615343/
https://ncbi.nlm.nih.gov/pubmed/18581587
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3349/ymj.2008.49.3.389
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados